Michael Aubrey
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transplantation, Haploidentical | 4 | 2024 | 23 | 0.750 |
Why?
| | HLA Antigens | 6 | 2026 | 241 | 0.630 |
Why?
| | HLA-DRB1 Chains | 4 | 2016 | 109 | 0.580 |
Why?
| | Epitopes | 4 | 2016 | 479 | 0.510 |
Why?
| | HLA-B Antigens | 3 | 2024 | 58 | 0.440 |
Why?
| | Receptors, KIR | 3 | 2026 | 123 | 0.390 |
Why?
| | Vimentin | 2 | 2016 | 47 | 0.370 |
Why?
| | Graft vs Host Disease | 3 | 2024 | 280 | 0.340 |
Why?
| | Peptides, Cyclic | 2 | 2016 | 276 | 0.330 |
Why?
| | Arthritis, Rheumatoid | 3 | 2016 | 1184 | 0.310 |
Why?
| | Graft Rejection | 2 | 2024 | 504 | 0.290 |
Why?
| | Alleles | 7 | 2026 | 900 | 0.280 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2026 | 207 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 5 | 2016 | 2455 | 0.240 |
Why?
| | Blood Group Incompatibility | 1 | 2024 | 21 | 0.210 |
Why?
| | ABO Blood-Group System | 1 | 2024 | 56 | 0.200 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.200 |
Why?
| | HLA-C Antigens | 1 | 2022 | 37 | 0.180 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2022 | 124 | 0.170 |
Why?
| | Recurrence | 1 | 2024 | 1125 | 0.160 |
Why?
| | Evolution, Molecular | 1 | 2024 | 501 | 0.160 |
Why?
| | Transplantation Conditioning | 2 | 2020 | 191 | 0.160 |
Why?
| | Tacrolimus | 1 | 2020 | 192 | 0.150 |
Why?
| | Pulmonary Alveolar Proteinosis | 1 | 2019 | 16 | 0.140 |
Why?
| | Islets of Langerhans | 3 | 1994 | 852 | 0.140 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1156 | 0.140 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2018 | 35 | 0.130 |
Why?
| | Heart Transplantation | 1 | 2024 | 679 | 0.130 |
Why?
| | Pregnancy Complications | 1 | 2023 | 605 | 0.130 |
Why?
| | Donor Selection | 1 | 2018 | 61 | 0.130 |
Why?
| | Gene Frequency | 4 | 2026 | 495 | 0.130 |
Why?
| | HLA-DR Antigens | 2 | 2020 | 211 | 0.110 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 466 | 0.110 |
Why?
| | Tissue Donors | 1 | 2018 | 398 | 0.110 |
Why?
| | Haplotypes | 4 | 2026 | 505 | 0.100 |
Why?
| | Insulin | 3 | 1994 | 2524 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 1994 | 845 | 0.100 |
Why?
| | Peptides | 2 | 2016 | 991 | 0.100 |
Why?
| | Genotype | 3 | 2026 | 1866 | 0.090 |
Why?
| | Cell Division | 1 | 1992 | 735 | 0.080 |
Why?
| | International Cooperation | 1 | 2011 | 192 | 0.080 |
Why?
| | Cyclophosphamide | 2 | 2022 | 275 | 0.080 |
Why?
| | Heart Failure | 1 | 2024 | 2323 | 0.080 |
Why?
| | Humans | 24 | 2026 | 145625 | 0.080 |
Why?
| | Graft Survival | 2 | 2024 | 508 | 0.080 |
Why?
| | Algorithms | 1 | 2018 | 1843 | 0.080 |
Why?
| | Histocompatibility Testing | 2 | 2020 | 122 | 0.080 |
Why?
| | Protein Binding | 2 | 2016 | 2239 | 0.070 |
Why?
| | Arachis | 1 | 2010 | 108 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2010 | 315 | 0.070 |
Why?
| | Peanut Hypersensitivity | 1 | 2010 | 143 | 0.070 |
Why?
| | Amino Acids | 1 | 2011 | 513 | 0.070 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2024 | 700 | 0.060 |
Why?
| | Mycobacterium Infections | 1 | 1987 | 55 | 0.060 |
Why?
| | Pakistan | 1 | 2026 | 83 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2010 | 899 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2022 | 365 | 0.060 |
Why?
| | India | 1 | 2026 | 213 | 0.060 |
Why?
| | Cricetinae | 3 | 1994 | 295 | 0.050 |
Why?
| | Genetics, Population | 1 | 2026 | 225 | 0.050 |
Why?
| | Middle Aged | 7 | 2024 | 36359 | 0.050 |
Why?
| | Genetic Variation | 2 | 2026 | 992 | 0.050 |
Why?
| | Male | 9 | 2026 | 73014 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2024 | 17291 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2011 | 3633 | 0.050 |
Why?
| | HLA-DP beta-Chains | 1 | 2024 | 88 | 0.050 |
Why?
| | HLA-A Antigens | 1 | 2022 | 52 | 0.050 |
Why?
| | Female | 9 | 2024 | 79080 | 0.050 |
Why?
| | Waiting Lists | 1 | 2024 | 242 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2022 | 102 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2024 | 5397 | 0.040 |
Why?
| | Myelodysplastic Syndromes | 1 | 2024 | 170 | 0.040 |
Why?
| | Interleukin-2 | 2 | 2000 | 434 | 0.040 |
Why?
| | Cell Line | 3 | 2016 | 2809 | 0.040 |
Why?
| | Catechols | 2 | 2000 | 14 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2024 | 8351 | 0.040 |
Why?
| | Hydroquinones | 2 | 2000 | 22 | 0.040 |
Why?
| | Adult | 6 | 2024 | 40821 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2014 | 3930 | 0.040 |
Why?
| | Biological Evolution | 1 | 2024 | 471 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 676 | 0.040 |
Why?
| | Aged | 4 | 2024 | 26251 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 14240 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 798 | 0.040 |
Why?
| | Fibroblasts | 2 | 1994 | 1033 | 0.030 |
Why?
| | Child, Preschool | 3 | 2024 | 11888 | 0.030 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 158 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2016 | 4112 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2018 | 72 | 0.030 |
Why?
| | Cell Transplantation | 1 | 1997 | 39 | 0.030 |
Why?
| | Proinsulin | 1 | 1997 | 54 | 0.030 |
Why?
| | Allografts | 1 | 2018 | 148 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2000 | 780 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2000 | 960 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2016 | 26 | 0.030 |
Why?
| | Mesocricetus | 2 | 1992 | 47 | 0.030 |
Why?
| | Collagen Type II | 1 | 2016 | 54 | 0.030 |
Why?
| | Cell Line, Transformed | 2 | 1992 | 137 | 0.030 |
Why?
| | Cohort Studies | 1 | 2026 | 6045 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 382 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2000 | 1223 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 369 | 0.030 |
Why?
| | Antigens, Viral, Tumor | 1 | 1994 | 7 | 0.030 |
Why?
| | Genetic Therapy | 1 | 1997 | 303 | 0.030 |
Why?
| | Tobacco Smoke Pollution | 1 | 1997 | 227 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 746 | 0.020 |
Why?
| | Cell Adhesion | 1 | 1994 | 447 | 0.020 |
Why?
| | Cell Communication | 1 | 1994 | 327 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6449 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2088 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2016 | 1160 | 0.020 |
Why?
| | Islets of Langerhans Transplantation | 1 | 1992 | 71 | 0.020 |
Why?
| | Cell Separation | 1 | 1992 | 300 | 0.020 |
Why?
| | Autoantibodies | 1 | 2019 | 1498 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2228 | 0.020 |
Why?
| | DNA | 1 | 1997 | 1418 | 0.020 |
Why?
| | Skin Tests | 1 | 2010 | 94 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7217 | 0.020 |
Why?
| | Infant | 1 | 2024 | 10093 | 0.020 |
Why?
| | Siblings | 1 | 2010 | 196 | 0.020 |
Why?
| | Glucose | 1 | 1994 | 1051 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11744 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1997 | 2007 | 0.020 |
Why?
| | Ethambutol | 1 | 1987 | 27 | 0.020 |
Why?
| | Rifampin | 1 | 1987 | 79 | 0.020 |
Why?
| | Animals | 5 | 1997 | 38030 | 0.010 |
Why?
| | HLA-B15 Antigen | 1 | 2006 | 12 | 0.010 |
Why?
| | Sequence Homology | 1 | 2006 | 42 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2006 | 269 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 611 | 0.010 |
Why?
| | United States | 1 | 2020 | 16041 | 0.010 |
Why?
| | Adolescent | 2 | 2014 | 22451 | 0.010 |
Why?
| | Base Sequence | 1 | 2006 | 2119 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2010 | 2910 | 0.010 |
Why?
| | Child | 2 | 2014 | 22638 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2006 | 2835 | 0.010 |
Why?
| | Plants, Toxic | 1 | 2000 | 18 | 0.010 |
Why?
| | Ganglionic Stimulants | 1 | 2000 | 15 | 0.010 |
Why?
| | Smoke | 1 | 2000 | 149 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1997 | 16 | 0.010 |
Why?
| | Nicotine | 1 | 2000 | 334 | 0.010 |
Why?
| | Receptors, Transferrin | 1 | 1997 | 28 | 0.010 |
Why?
| | 3T3 Cells | 1 | 1997 | 152 | 0.010 |
Why?
| | Insulin, Long-Acting | 1 | 1997 | 65 | 0.010 |
Why?
| | Antioxidants | 1 | 2000 | 544 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1997 | 526 | 0.010 |
Why?
| | Cyclosporine | 1 | 1997 | 256 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 1997 | 415 | 0.010 |
Why?
| | Mice, Inbred NOD | 1 | 1997 | 598 | 0.010 |
Why?
| | Transfection | 1 | 1997 | 914 | 0.010 |
Why?
| | Iron | 1 | 1997 | 359 | 0.010 |
Why?
| | Cell Survival | 1 | 1997 | 1102 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 1997 | 824 | 0.010 |
Why?
| | RNA | 1 | 1997 | 925 | 0.010 |
Why?
| | Mice | 2 | 1997 | 18266 | 0.000 |
Why?
| | Liver | 1 | 1997 | 1859 | 0.000 |
Why?
| | Blood Glucose | 1 | 1997 | 2357 | 0.000 |
Why?
| | Cell Differentiation | 1 | 1992 | 1979 | 0.000 |
Why?
|
|
Aubrey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|